Myeloid Marker Polyclonal Antibody, AbBy Fluor-750 Conjugated
Applications
Reactivity
Predicted Reactivity
| Overview | |
| Catalog # | bs-19143R-BF750-100uL |
| Product Name | Myeloid Marker Polyclonal Antibody, AbBy Fluor-750 Conjugated |
| Applications |
WB
IF(IHC-P)
IF(IHC-F)
IF(ICC)
|
| Specificity | This antibody's immunogen sequence has 91% homology (10/11 residues) with the Rat MYADM protein and is predicted to work with Rat samples |
| Reactivity | Human |
| Predicted Reactivity | Pig, Horse, Rabbit |
| Specifications | |
| Conjugation | AbBy Fluor-750 |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from human MYADM |
| Clonality | Polyclonal |
| Isotype | IgG |
| Concentration | 1ug/ul |
| Purification | Purified by Protein A. |
| Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target | |
| Gene ID | 91663 |
| Swiss Prot | Q96S97 |
| Subcellular location | Cell membrane |
| Synonyms | MYADM; MYADM_HUMAN; myeloid associated differentiation marker; Myeloid upregulated protein; Myeloid-associated differentiation marker; Protein SB135. |
| Background | Myeloid-associated differentiation marker (MYADM) is a member of the MAL family with the unique features of having eight transmembrane regions and a ubiquitous pattern of expression and of being found localized at the plasma membrane. MYADM has been found to be associated with the differentiation of hematopoietic cells or acute promyelocytic leukemia cells. MYADM could serve as a new marker for hematopoietic differentiation and is a target for diagnostic, prognostic and/or therapeutic interventions. |
| Application Dilution | |
| WB | 1:300-5000 |
| IF(IHC-P) | 1:50-200 |
| IF(IHC-F) | 1:50-200 |
| IF(ICC) | 1:50-200 |
Frequently asked questions
Which applications is Myeloid Marker Polyclonal Antibody, AbBy Fluor-750 Conjugated (bs-19143R-BF750) validated for, and at what dilution?
bs-19143R-BF750 is validated for WB (1:300-5000); IF(IHC-P) (1:50-200); IF(IHC-F) (1:50-200); IF(ICC) (1:50-200). These are recommended starting dilutions; optimal dilutions should be determined by the end user.
Which species does Myeloid Marker Polyclonal Antibody, AbBy Fluor-750 Conjugated (bs-19143R-BF750) react with?
Tested reactivity: Human. Predicted reactivity (expected from sequence homology but not yet tested): Pig, Horse, Rabbit.
How should bs-19143R-BF750 be stored?
Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. Storage buffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
What immunogen was used to raise Myeloid Marker Polyclonal Antibody, AbBy Fluor-750 Conjugated (bs-19143R-BF750)?
KLH conjugated synthetic peptide derived from human MYADM
What are the excitation and emission wavelengths of the AbBy Fluor-750 conjugate (bs-19143R-BF750)?
AbBy Fluor-750 on bs-19143R-BF750: excitation / emission 749nm/775nm.
